3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Prostatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Waldenstrom Macroglobulinemia
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Prolymphocytic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hemangioma, Cavernous, Central Nervous System
1
Heart Failure
1
Interventions
Tacrolimus
29
fludarabine phosphate
21
Methotrexate
21
Cyclophosphamide
21
Mycophenolic Acid
18
Busulfan
15
Antilymphocyte Serum
14
Whole-Body Irradiation
13
Sirolimus
12
fludarabine
11
Peripheral Blood Stem Cell Transplantation
11
Cyclosporine
9
thymoglobulin
8
Melphalan
8
Hematopoietic Stem Cell Transplantation
6
Granulocyte Colony-Stimulating Factor
6
Filgrastim
6
Rituximab
5
Pentostatin
5
Methylprednisolone
5
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Cyclosporins
4
ruxolitinib
3
Vorinostat
3
Transplantation
3
Flow Cytometry
3
Etoposide
3
merphos
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Graft vs Host Disease
×
Atorvastatin
×
Clear all
No trials found.